|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1994-11-4
|
|
pubmed:abstractText |
To evaluate the effect of the combination of vincristine, dactinomycin, and doxorubicin with (regimen J) or without (regimen DD-RT) cyclophosphamide on the relapse-free survival of children with stages II to IV Wilms' tumor and focal or diffuse anaplasia.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2126-31
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7931483-Anaplasia,
pubmed-meshheading:7931483-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7931483-Child,
pubmed-meshheading:7931483-Child, Preschool,
pubmed-meshheading:7931483-Combined Modality Therapy,
pubmed-meshheading:7931483-Cyclophosphamide,
pubmed-meshheading:7931483-Dactinomycin,
pubmed-meshheading:7931483-Disease-Free Survival,
pubmed-meshheading:7931483-Doxorubicin,
pubmed-meshheading:7931483-Female,
pubmed-meshheading:7931483-Humans,
pubmed-meshheading:7931483-Kidney Neoplasms,
pubmed-meshheading:7931483-Male,
pubmed-meshheading:7931483-Neoplasm Staging,
pubmed-meshheading:7931483-Prognosis,
pubmed-meshheading:7931483-United States,
pubmed-meshheading:7931483-Vincristine,
pubmed-meshheading:7931483-Wilms Tumor
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.
|
|
pubmed:affiliation |
Department of Pediatrics, Roswell Park Cancer Institute, School of Medicine, State University of New York at Buffalo 14263.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial,
Multicenter Study
|
